Abstract | OBJECTIVE: METHOD: A selective review of the literature is presented in the service of describing the estimated prevalence of ADHD among children and adolescents, its core clinical features, evidence concerning psychopharmacological and psychosocial treatment effects, and related research issues and trends leading to the development of the MTA. RESULTS: Despite decades of treatment research and clinical practice, there is an insufficient basis for answering the following manifold question: under what circumstances and with what child characteristics (comorbid conditions, gender, family history, home environment, age, nutritional/metabolic status, etc.) do which treatments or combinations of treatment (stimulants, behavior therapy, parent training, school-based intervention) have what impacts (improvement, stasis, deterioration) on what domains of child functioning (cognitive, academic, behavioral, neurophysiological, neuropsychological, peer relations, family relations), for how long (short versus long term), to what extent (effect sizes, normal versus pathological range), and why (processes underlying change)? CONCLUSIONS: The important scientific, clinical, and public health issues nested within this manifold question provide both the impetus and scaffolding for the MTA.
|
Authors | J E Richters, L E Arnold, P S Jensen, H Abikoff, C K Conners, L L Greenhill, L Hechtman, S P Hinshaw, W E Pelham, J M Swanson |
Journal | Journal of the American Academy of Child and Adolescent Psychiatry
(J Am Acad Child Adolesc Psychiatry)
Vol. 34
Issue 8
Pg. 987-1000
(Aug 1995)
ISSN: 0890-8567 [Print] United States |
PMID | 7665456
(Publication Type: Journal Article, Review)
|
Topics |
- Adolescent
- Attention Deficit Disorder with Hyperactivity
(complications, epidemiology, therapy)
- Child
- Clinical Trials as Topic
- Combined Modality Therapy
(methods)
- Humans
- Multicenter Studies as Topic
- National Institutes of Health (U.S.)
- United States
(epidemiology)
|